TRIM21 and interstitial lung disease: MAA frequently appears in cases of myositis overlap syndrome, yet it’s a group of antibodies linked to the disease and lacks specificity, including anti-TRIM21, which is frequently linked to a heightened risk of concurrent ILD (153).